Özer Algan
About
In The Last Decade
Özer Algan
53 papers receiving 738 citations
Hit Papers
Peers
Comparison fields: 5 of 63
- Pulmonary and Respiratory Medicine 344
- Radiation 239
- Genetics 198
- Radiology, Nuclear Medicine and Imaging 193
- Cancer Research 117
Countries citing papers authored by Özer Algan
This map shows the geographic impact of Özer Algan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Özer Algan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Özer Algan more than expected).
Fields of papers citing papers by Özer Algan
This network shows the impact of papers produced by Özer Algan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Özer Algan. The network helps show where Özer Algan may publish in the future.
Co-authorship network of co-authors of Özer Algan
This figure shows the co-authorship network connecting the top 25 collaborators of Özer Algan. A scholar is included among the top collaborators of Özer Algan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Özer Algan. Özer Algan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | NRG Oncology/RTOG1205: A Randomized Phase II Trial of Concurrent Bevacizumab and Reirradiation Versus Bevacizumab Alone as Treatment for Recurrent Glioblastoma breakdown → | 104 |
| 3 | Radiation Therapy For Early Stage Breast Cancer | 4 |
| 4 | 2 | |
| 5 | 7 | |
| 6 | 1 | |
| 7 | 2 | |
| 8 | 6 | |
| 9 | 12 | |
| 10 | 1 | |
| 11 | 2 | |
| 12 | 16 | |
| 13 | 28 | |
| 14 | 1 | |
| 15 | 6 | |
| 16 | 5 | |
| 17 | 29 | |
| 18 | 42 | |
| 19 | 40 | |
| 20 | 53 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.